nivolumab,ipilimumab
bms
['melanoma', 'nivo', ' ipi ']
#esmo2022 melanoma session- prof. dirk schaddendorf presenting os benefit from adjuvant high dose ipi (3) + nivo (1) in resected/radiated stage iv melanoma - immuned study now published in . impressive outcome including some patients with brain mets post-srs 
#Melanoma medical oncologist and #immunotherapy & drug development investigator at @MDAndersonNews. Co-Director of the #BrainMets Clinic. Views are my own.